HF
SWTX

HRT Financial’s SpringWorks Therapeutics SWTX Stock Holding History

HRT Financial’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,414
Closed -$238K – 3496
2025
Q1 		$238K Sell
5,414
-2,693
-33% -$124K ﹤0.01% 1911
2024
Q4 		$292K Buy
+8,107
New +$283K ﹤0.01% 1734
2024
Q1 		– Sell
-116,606
Closed -$4.26M – 3065
2023
Q4 		$4.26M Buy
+116,606
New +$3.04M 0.03% 355
2023
Q2 		– Sell
-16,558
Closed -$426K – 3257
2023
Q1 		$426K Buy
+16,558
New +$484K 0.01% 1492

Other funds holding SWTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

HRT Financial's SWTX Position: Q2 2025 in Review

HRT Financial sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 5,414 shares — an estimated $238K sold.

HRT Financial first reported a position in SWTX in Q1 2023 and held it in 4 quarters. The position peaked at $4.26M in Q4 2023. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • HRT Financial reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 5,414 SpringWorks Therapeutics shares in Q2 2025, an estimated $238K.
  • HRT Financial first reported a position in SpringWorks Therapeutics in Q1 2023 and held it in 4 quarters.
  • HRT Financial's SpringWorks Therapeutics position peaked at $4.26M in Q4 2023.
  • 222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.